"It is always better to buy high growth where the intrinsic value is growing, at an unreasonable price. Look for these diamonds in the stock market."
This is a fascinating and potent statement that gets to the very heart of active investing. Let's break it down, expand on its principles, and then debate its merits and pitfalls.
Discussion: Deconstructing the Statement
The statement, "Always better to buy high growth where the intrinsic value is growing, at an unreasonable price," contains three critical components:
High Growth & Growing Intrinsic Value: This is the core of what you're buying. You're not just buying a ticker symbol; you're buying a share in a business that is fundamentally becoming more valuable over time. Intrinsic value is the present value of all future cash flows the company is expected to generate. A "high growth" company is one where these future cash flows are projected to increase at a rapid rate. The key here is the sustainability and quality of that growth. Is it driven by a durable competitive advantage (a "moat"), a revolutionary product, or a massive market trend?
"At an Unreasonable Price": This is the controversial twist. Conventional wisdom (especially from value investors like Benjamin Graham) is to never overpay. This statement argues that for the right company, even a price that looks expensive by standard metrics (like P/E ratio) can be justified. The "unreasonableness" is in the eyes of the beholder—it looks unreasonable today based on current earnings, but may look cheap in hindsight several years from now when the company's earnings have exploded.
"Diamonds in the Stock Markets": This is the outcome. These are the companies that defy conventional valuation, compound wealth at extraordinary rates for decades, and become the Amazons, Teslas, or Mercados of the world. They are "diamonds" because they are rare, incredibly valuable, and often hidden in plain sight or misunderstood by the market.
Expansion: The Philosophy in Practice (The "How-To")
This approach is the bedrock of Growth Investing, championed by legends like Philip Fisher, and later, T. Rowe Price and William J. O'Neil. It's also closely related to the concept of Compounding Machines that Charlie Munger and Warren Buffett (in his later years) often discuss.
How does an investor operationalize this?
Look Beyond the Trailing Multiples: Don't screen out stocks just because they have a high P/E ratio of 80. Instead, ask: What will its earnings be in 5 years? If earnings are expected to grow 40% per year, that P/E of 80 can quickly become a very reasonable P/E of 15 on future earnings.
Focus on the TAM (Total Addressable Market): Is the company operating in a niche market or a massive, expanding ocean? A company with a $10 billion TAM has a natural growth cap; one with a $1 trillion TAM has runway for decades.
Assess the Moat: What prevents competitors from eroding those high growth rates? Is it network effects (Facebook), brand power (Apple), proprietary technology (Adobe), or relentless innovation (Tesla)?
Management Quality: Are the founders and leaders visionaries who are capital allocators and long-term builders? Philip Fisher's "scuttlebutt" method—researching a company through employees, competitors, and customers—is key here.
Reinvestment Potential: Is the company able to reinvest its profits back into the business at similarly high rates of return? This is the engine of compounding.
Debate: The Perils and Counterarguments
This strategy is seductive but fraught with danger. For every diamond, there are countless pieces of glass that look similar.
The Bull Case (Why the Statement Can Be True):
The Power of Compounding: A business growing at 25% per year will see its earnings double in less than 3 years. Paying a "high price" today can be trivial if you are certain (or highly confident) about this growth trajectory.
Opportunity Cost: The biggest risk in investing is often not losing money, but missing out on gigantic gains. Being too conservative and avoiding "unreasonably priced" growth stocks can mean missing entire technological revolutions.
Market Myopia: The market often undervalues the long-term potential of disruptive companies because it's fixated on next quarter's earnings. This creates the "unreasonable price" opportunity for those with a longer time horizon.
The Bear Case (The Dangers and Flaws):
The Valuation Trap: The graveyard of stock markets is filled with "can't-miss" growth companies that were bought at absurd prices during hype cycles (see the Dot-com bubble). When growth inevitably slows or fails to meet sky-high expectations, the valuation multiple contracts violently, leading to catastrophic losses (the "double whammy").
The Difficulty of Prediction: It is incredibly hard to predict growth rates years into the future. Competition, technological disruption, regulatory changes, and simple execution errors can derail even the most promising companies. Betting on a long-shot growth story is often just speculation disguised as investing.
Confirmation Bias: Investors who fall in love with a story tend to seek out information that confirms their belief and ignore red flags. The phrase "intrinsic value is growing" can become an article of faith rather than a dispassionate analysis.
The "Always" Problem: The word "always" is almost always wrong in investing. A rigid strategy that ignores margin of safety entirely is reckless. There are times when the price is so detached from any plausible future reality that no amount of growth can justify it.
The Value Investor's Rebuttal: A traditional value investor would argue that paying an "unreasonable price" eliminates your Margin of Safety—the central tenet of value investing. This margin is what protects you when your assumptions are wrong. By abandoning it, you are taking on uncompensated risk.
Conclusion: A Nuanced Verdict
The statement is a powerful half-truth.
It is true that the single best way to generate life-changing wealth in the stock market is to identify and hold exceptional, high-growth companies for the long term. In this pursuit, being too focused on short-term valuation metrics can cause you to miss these rare "diamonds."
However, it is dangerously false to suggest that the price you pay doesn't matter "always." Paying an egregious price, even for a great company, can lead to a decade of poor returns.
The synthesis lies in a more balanced approach:
Seek extraordinary businesses first. Focus on identifying those with durable moats, massive TAMs, and superb management—the ones where the intrinsic value is genuinely and predictably growing.
Then, be a smart shopper. Even when you find a diamond, you shouldn't pay a king's ransom for it if you can help it. Try to buy it at a "reasonable price for a great company" rather than an "unreasonable price."
Differentiate between "Expensive" and "Overvalued." An expensive stock (high P/E) can be a good buy if its growth prospects are underestimated. An overvalued stock is one where even the most optimistic growth scenarios cannot justify the current price.
In the end, the quest for these diamonds is the holy grail of investing. But the most successful investors are those who can combine the growth investor's vision for the future with the value investor's discipline about the price.